Holen Sie sich die Stockscreener-App
4.40
14.17%
-0.75
Schlusskurs vom Vortag:
$5.15
Offen:
$5
24-Stunden-Volumen:
1.09M
Relative Volume:
0.31
Marktkapitalisierung:
$13.99M
Einnahmen:
$129.20K
Nettoeinkommen (Verlust:
$-7.44M
KGV:
-0.3932
EPS:
-11.19
Netto-Cashflow:
$-8.62M
1W Leistung:
-54.76%
1M Leistung:
+271.43%
6M Leistung:
+121.00%
1J Leistung:
-35.68%
1-Tages-Spanne:
$4.1616
$5.04
1-Wochen-Bereich:
$4.1616
$10.34
52-Wochen-Spanne:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Firmenname
Sonnet Biotherapeutics Holdings Inc
Sektor
Branche
Telefon
609-375-2227
Adresse
100 OVERLOOK CENTER, PRINCETON, NJ
Vergleichen Sie SONN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
4.42 | 30.52M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.26 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.96 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.89 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
570.40 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
293.80 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc Aktie (SONN) Neueste Nachrichten
What drives Sonnet BioTherapeutics Holdings Inc. stock priceRecord-setting profit potential - jammulinksnews.com
What analysts say about Sonnet BioTherapeutics Holdings Inc. stockDouble or triple returns - jammulinksnews.com
Is Sonnet BioTherapeutics Holdings Inc. a good long term investmentExplosive earnings growth - Autocar Professional
Sonnet BioTherapeutics Holdings Inc. Stock Analysis and ForecastPowerful market insights - jammulinksnews.com
Halper Sadeh investigates Sonnet BioTherapeutics, First Community Corp, Monogram Technologies mergers. - AInvest
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders - GlobeNewswire Inc.
Biotech Minnow Sonnet Takes A Hard Turn Into Crypto - Finimize
Sonnet BioTherapeutics Secures Funding to Meet Nasdaq Requirements - TipRanks
Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors - ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sonnet BioTherapeutics Bets Big on HYPE Token as Charts Signal 161% Rally Potential - CoinChapter
Sonnet BioTherapeutics’ New Strategy with $888 Million Worth of Crypto Reserves! - Pintu
Sonnet BioTherapeutics Launches $583 Million Crypto Treasury With HYPE Token - AInvest
Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price - Cointelegraph
Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury - Tekedia
Biotech Firm Sonnet Pivots to Crypto Treasury Strategy in $888M HYPE Token Deal - blockhead.co
Best Biotech Stocks Worth Watching – July 14th - Defense World
What makes Sonnet BioTherapeutics Holdings Inc. stock price move sharplyVerified Return Tips - Newser
$888M Crypto Pivot: Nasdaq Biotech Firm Goes All-In on HYPE Token with Bold Treasury Bet - CryptoNinjas
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionHigh Probability Setups - Newser
How Sonnet BioTherapeutics Holdings Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
Sonnet BioTherapeutics Launches $888M Crypto Treasury Strategy - The Crypto Times
Sonnet BioTherapeutics Announces Merger with Rorschach I LLC - The Globe and Mail
Crypto Deal Boosts Sonnet BioTherapeutics Share Price By 260% - Happy Coin News
Sonnet BioTherapeutics Merges in $888M Deal to Launch Hyperliquid Strategies and HYPE Treasury - The Currency analytics
PLTR, TTD, TLRY, SONN, TSLA: 5 Trending Stocks TodaySonnet BioTherapeutics (NASDAQ:SONN), Palantir Technologies (NASDAQ:PLTR) - Benzinga
Hyperliquid's Price Drops 2.82% Amid Nasdaq Listing Through Sonnet BioTherapeutics Merger - AInvest
Small Healthcare Stocks Enjoy Big Wins On Deal News - Finimize
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant - NewsBreak: Local News & Alerts
Sonnet BioTherapeutics Holdings Inc (SONN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
Atlas Merchant Capital LLC entered into a definitive agreement to acquire Sonnet BioTherapeutics Holdings, Inc. in a reverse merger transaction. - MarketScreener
Massive deal sends biotech stock rallying 367% - Yahoo Finance
Sonnet BioTherapeutics Agrees $888M Merger as It Launches Strategic HYPE Treasury - NFTgators
Hyperliquid Strategies Inc. to Hold $583 Million in HYPE Tokens Post Merger - AInvest
New Nasdaq-Listed Company, Hyperliquid Strategies, to Hold $583M in HYPE Tokens - CryptoRank
Crude Oil Moves Lower; Daré Bioscience Shares JumpDiginex (NASDAQ:DGNX), Dare Bioscience (NASDAQ:DARE) - Benzinga
Sonnet Biotherapeutics shares surge 59.85% intraday after announcing an $888 million business combination to launch a HYPE cryptocurrency treasury reserve strategy. - AInvest
HYPE coin price up 200%, Sonnet BioTherapeutics merges into Hyperliquid Strategies - Invezz
Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday? - Benzinga
Sonnet ditches biotech dreams to anchor a $583m HYPE token reserve - Crypto News
Finanzdaten der Sonnet Biotherapeutics Holdings Inc-Aktie (SONN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):